📄 Abstract
Background Pharmacovigilance, defined by the World Health Organisation as 'the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem' plays a key role in ensuring that patients receive safe drugs. Our knowledge of a drug's adverse reactions can be increased by various means, including spontaneous reporting, inten- sive monitoring and database studies. New processes, both at a regulatory and a scientific level, are being developed with the aim of strengthening pharmacovigilance. On a regulatory level, these include conditional approval and risk management plans; on a scientific level, transparency and increased patient involvement are two important elements. Objective To review and discuss various aspects of phar- macovigilance, including new methodological developments.
🏷️ Keywords
📚 How to Cite:
Shivam M. Yadav, Sunil S. Jaybhaye, Ashwini J Bahir , PHARMACOVIGILANCE: METHODS, RECENT DEVELOPMENTS AND FUTURE PERSPECTIVES , Volume 12 , Issue 5, May 2026, EPRA International Journal of Multidisciplinary Research (IJMR) ,